Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  osteoporosis 




 
Kaplan Qbank USMLE



Author3 Posts
  #1

at which T score on DEXA scan should start start treatment w/ bisphosphonate?

___________________
"Our greatest glory is not in never falling but in rising every time we fall." --Confucius

  #2

T-Score

The T-score shows where your patient is compared to the population. In other words, an Irish woman with a small frame stacks up differently than an African American woman with a larger frame, and you want to know how they compare to people of their own sex, race, age, height and weight.

The T-score predicts fracture risk: For every -1 standard deviation the fracture risk doubles.

T-score = 0 has average risk for a normal 40 year old.
T-score = -1 has twice the risk.
T-score = -2 has 4 times the risk
T-score = -3 has 8 times the risk.

Notice that the T-score decreases by -1 for about every 10% of bone lost (i.e., a person with 90% of young adult normal bone density will tend to have a T-score of about -1).

The other big reason to notice the T-score is that the World Heath Organization defines osteoporosis on the basis of T-scores.

T -1 or higher = Normal
T -2.5 to -1 = Osteopenia
T below -2.5 = Osteoporosis
T below -2.5 + fragility fracture = Severe osteoporosis

# Women with a below-normal bone density of 2.5 SD or greater and who have no history of fractures should take bisphosphonates.

# Women with below-normal bone density 1 SD or more and have a history of fractures should consider bisphosphonates.

___________________
Don't live in a town where there are no doctors

  #3

Thanks a lot, Justice!smiling face

___________________
"Our greatest glory is not in never falling but in rising every time we fall." --Confucius







You don't have permission to post.




Login or Register to post messages in this topic





















Contact | Leaders | Disclaimer | Privacy

Copyright @ Prep for USMLE. All rights reserved.